Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, ≥25 years of age, with NILM cytology

Increasing evidence suggests that extended human papillomavirus (HPV) genotyping (beyond 16/18) is effective for risk stratification in women with normal cytology. This report provides extended genotyping results, using the BD Onclarity HPV Assay, for individual genotypes HPV16, 18, 31, 45, 51, and...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Gynecologic oncology 2019-04, Vol.153 (1), p.26-33
Hauptverfasser:	Stoler, Mark H., Wright, Thomas C., Parvu, Valentin, Yanson, Karen, Cooper, Charles K., Andrews, Jeffrey
Format:	Artikel
Sprache:	eng
Schlagworte:	Cervical Cancer screening Cervical intraepithelial neoplasia Extended genotyping Human papillomavirus Negative for intraepithelial lesions or malignancies Risk stratification
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!